Search
Conozca las preguntas que debe hacerle a un médico especialista en cáncer pulmonar después de recibir el diagnóstico, de la mano de un especialista de MSK que ha tratado con éxito a muchas personas con cáncer pulmonar.
The first-ever clinical trial of a new kind of drug, called pirtobrutinib or LOXO-305, has shown promising results in a phase I/II study.
MSK head and neck surgeons are investigating novel imaging methods that enable them to detect and visualize cancer cells during an operation.
Find out what it’s like to undergo cancer treatment when you work at a cancer hospital like Memorial Sloan Kettering.
Following surgery to remove NF2 tumors in her brain, MSK patient Maggie Chess developed a sudden passion and talent for abstract painting, a rare outcome that has transformed her life.
Saad Usmani, MD, has been named Chief of the Myeloma Service at Memorial Sloan Kettering Cancer Center.
Along with Valentine's Day, February marks American Heart Month. MSK’s Vice Chair of Radiation Oncology, Dr Oren Cahlon talks on how his team are making radiation-induced heart disease “a thing of the past” for our breast cancer patients.
All radiotherapy treatments for prostate cancer should be accompanied by image-guidance of the prostate position to rule out significant setup errors in fractional delivery.
Very low-dose radiotherapy (VLDRT) is effective for treating grade 3A follicular lymphoma and provides patients with a shorter treatment course and fewer side effects.
Dr. Deb Schrag, Chair of the Department of Medicine, and Dr. Lorenz Studer, Director of the Center for Stem Cell Biology at Memorial Sloan Kettering Cancer Center (MSK), have been elected to the National Academy of Medicine (NAM), one of the highest honors bestowed upon scientists worldwide.